Ronald Guido
Keine laufenden Positionen mehr
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Sandra Gurrola | F | 57 | 3 Jahre | |
Mark Hensley | M | - | 8 Jahre | |
Stacy Wheeler | F | - | 8 Jahre | |
Noel Barnard | M | - | 8 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Mark Leuchtenberger | M | 67 |
Eterna Therapeutics LLC
Eterna Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Eterna Therapeutics, Inc., Eterna Therapeutics LLC is a clinical-stage biopharmaceutical company based in New York, NY. The company is focused on exploring the role that cytokine-based therapy can have on the immune system in treating patients with cancer. Eterna Therapeutics is committed to developing irx-2, a novel cytokine-based therapy, to treat patients with cancer. The active constituents of irx-2, namely interleukin-2 (il-2) and other key cytokines, are postulated to signal, enhance and restore immune function suppressed by the tumor, thus enabling the immune system to attack cancer cells. Eterna Therapeutics is a late clinical-stage biopharmaceutical company focused on il-2 cytokine-based therapies in treating patients with cancer. Eterna Therapeutics was acquired by NTN Buzztime, Inc. on March 25, 2021 for $213.30 million.
IRX Therapeutics, Inc.
IRX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology IRX Therapeutics, Inc. provides pharmaceutical products. Its therapies are designed to target and restore the immune system in order to improve a patient's response to next-generation cancer vaccines and novel targeted therapeutics. The company was founded in 1994 and is headquartered in New York, NY. | 2 Jahre |
Johnny Stilou | M | 57 | 8 Jahre | |
Mette Agger | F | 59 | 8 Jahre | |
Michael Heffernan | M | 59 | 5 Jahre | |
Howard Federoff | M | 71 | 1 Jahre | |
Luba Greenwood | F | 45 |
IRX Therapeutics, Inc.
IRX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology IRX Therapeutics, Inc. provides pharmaceutical products. Its therapies are designed to target and restore the immune system in order to improve a patient's response to next-generation cancer vaccines and novel targeted therapeutics. The company was founded in 1994 and is headquartered in New York, NY. | 1 Jahre |
John D. Weinberg | M | 57 | 6 Jahre | |
Ira Duarte | F | 55 | 7 Jahre | |
Alastair Stuart McEwan | M | 69 | 1 Jahre | |
Charles Cherington | M | 61 | 2 Jahre | |
Jay Sial | M | 60 | - | |
Robert Radie | M | 60 | 4 Jahre | |
William Polvino | M | 63 | 6 Jahre | |
Paul Wotton | M | 63 | 4 Jahre | |
Kim Björnstrup | M | - | - | |
Lars Kåre Viksmoen | M | 75 | - | |
Dennis Langer | M | 73 | 1 Jahre | |
Craig Collard | M | 58 | 6 Jahre | |
Paul Edick | M | 67 | 3 Jahre | |
Erich Mohr | M | 70 | 1 Jahre | |
Kurt Anker Nielsen | M | 78 | 7 Jahre | |
Timothy Charles Melkus | M | 65 | - | |
Edward Penhoet | M | 83 | 2 Jahre | |
Thomas Dyrberg | M | 69 | 13 Jahre | |
Srinivas Rao | M | 55 | 1 Jahre | |
Michelle McGuinness | F | - | - | |
Lynn Sadowski Mason | F | 45 | 2 Jahre | |
Michael Gottlieb | M | 54 | - | |
Jesse Shefferman | M | 52 | 3 Jahre | |
Susan Miller | F | 44 | - | |
Richard Isaac Simtob | M | 54 | - | |
Breian Knudsen | M | - | 9 Jahre | |
Kevin D'Amour | M | 51 | 1 Jahre | |
Alvin Shih | M | 47 | 2 Jahre | |
Jeff Paley | M | 55 | 1 Jahre | |
Yiannis A. Monovoukas | M | 62 | - | |
Edward E. Koval | M | 62 | - | |
Walter C. Ogier | M | 67 |
IRX Therapeutics, Inc.
IRX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology IRX Therapeutics, Inc. provides pharmaceutical products. Its therapies are designed to target and restore the immune system in order to improve a patient's response to next-generation cancer vaccines and novel targeted therapeutics. The company was founded in 1994 and is headquartered in New York, NY. | - |
Allen Wolff | M | 52 | - | |
Robert Dufour | M | - | - | |
George Denny | M | - | - | |
Nicholas Singer | M | 44 | - | |
Maged Shenouda | M | 59 | - | |
Roger Sidhu | M | 48 | 2 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 24 | 50,00% |
Dänemark | 24 | 50,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Ronald Guido
- Persönliches Netzwerk